These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 11514908)
21. Preventive Strategies for Respiratory Syncytial Virus Infection in Young Infants. Taveras J; Ramilo O; Mejias A Neoreviews; 2020 Aug; 21(8):e535-e545. PubMed ID: 32737172 [TBL] [Abstract][Full Text] [Related]
22. Risk-Scoring Tool for respiratory syncytial virus prophylaxis in premature infants born at 33-35 completed weeks' gestational age in Canada. Paes B; Steele S; Janes M; Pinelli J Curr Med Res Opin; 2009 Jul; 25(7):1585-91. PubMed ID: 19469698 [TBL] [Abstract][Full Text] [Related]
23. RSV Prevention Within Reach for Older Infants and Toddlers: The Role of Active Immunization. Mejias A; Ramilo O J Pediatric Infect Dis Soc; 2024 Jul; 13(Supplement_2):S125-S130. PubMed ID: 38995087 [TBL] [Abstract][Full Text] [Related]
24. RSV disease--is there a role for prevention? Lenney W Respir Med; 2001 Mar; 95(3):170-2. PubMed ID: 11266232 [No Abstract] [Full Text] [Related]
25. Active prophylaxis for respiratory syncytial virus: current knowledge and future perspectives. Vittucci AC; Zangari P; Ciarlitto C; Di Camillo C; Grandin A; Cotugno N; Marchili MR; Villani A Minerva Pediatr; 2018 Dec; 70(6):566-578. PubMed ID: 30334621 [TBL] [Abstract][Full Text] [Related]
26. Respiratory syncytial virus immunization program for the United States: impact of performance determinants of a theoretical vaccine. Régnier SA Vaccine; 2013 Sep; 31(40):4347-54. PubMed ID: 23896421 [TBL] [Abstract][Full Text] [Related]
34. New strategies for control of respiratory syncytial virus infection. Nokes JD; Cane PA Curr Opin Infect Dis; 2008 Dec; 21(6):639-43. PubMed ID: 18978532 [TBL] [Abstract][Full Text] [Related]
35. Advances in RSV vaccine research and development - A global agenda. Higgins D; Trujillo C; Keech C Vaccine; 2016 Jun; 34(26):2870-2875. PubMed ID: 27105562 [TBL] [Abstract][Full Text] [Related]
36. In Hot Pursuit of the First Vaccine Against Respiratory Syncytial Virus. Kim JY; Chang J Yonsei Med J; 2016 Jul; 57(4):809-16. PubMed ID: 27189271 [TBL] [Abstract][Full Text] [Related]
37. Clinical and epidemiologic features of respiratory syncytial virus. Hall CB; Simőes EA; Anderson LJ Curr Top Microbiol Immunol; 2013; 372():39-57. PubMed ID: 24362683 [TBL] [Abstract][Full Text] [Related]
38. A single, low dose of a cGMP recombinant BCG vaccine elicits protective T cell immunity against the human respiratory syncytial virus infection and prevents lung pathology in mice. Céspedes PF; Rey-Jurado E; Espinoza JA; Rivera CA; Canedo-Marroquín G; Bueno SM; Kalergis AM Vaccine; 2017 Feb; 35(5):757-766. PubMed ID: 28065474 [TBL] [Abstract][Full Text] [Related]